Abstract
Introduction: Ozanimod is a selective sphingosine 1-phosphate receptor 1 and 5 modulator under development by Celgene, for the treatment of relapsing ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
